2m 2m 2m 2m 2m 2m 2m
Regenicin (RGIN)
OTC
$0.000001$0.00 (0.00%)
Price as of Mar 30, 2026- $15,348.00Market Cap
- -99.00%1-Year Change
- BiotechnologyIndustry
Regenicin (RGIN)
$0.000001$0.00 (0.00%)
RGIN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.00 | ||
Change | $0.00 (0.00%) | ||
Open | $0.00 | ||
High | $0.00 | ||
Low | $0.00 | ||
Previous Close | $0.00 | ||
Volume | 26,300 | ||
30-Day Average Volume | 25,650 | ||
1-Week Change | 0.00% | ||
1-Month Change | -99.00% | ||
1-Year Change | -99.00% | ||
3-Year Change | -99.93% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 153.5M | ||
Total Assets | $11.9M | ||
Market Cap | $15,348.00 | ||
Enterprise Value | -$10.0M | ||
Period: QTR TTM FY | |||
Revenue | -$200.00 | ||
Net Income | -$336,435.00 | ||
Free Cash Flow | $0.00 | ||
EBIT | -$327,186.00 | ||
EBITDA | -$327,186.00 | ||
Net Working Capital | -$19.0M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | 31 | ||
Enterprise Value/Revenue | 50,042 | ||
P/B | -0 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||